Pharma Mar S.A. (PHM) — Capital Reinvestment Ratio

Latest as of December 2025: 0.19x

Pharma Mar S.A. (PHM) has a Capital Reinvestment Ratio of 0.19x as of December 2025, meaning it reinvests 0% of its operating cash flow (€33.58 Million) in capital expenditures (€6.26 Million). Check Pharma Mar S.A. (PHM) tangible net worth to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.19x
Capex / Operating Cash Flow

Operating Cash Flow

€33.58 Million
EUR

Capital Expenditures

€6.26 Million
EUR

Data as of

Dec 2025
Most recent filing

Pharma Mar S.A. Capital Reinvestment Ratio (2012–2025)

This chart tracks Pharma Mar S.A.'s Capital Reinvestment Ratio across 9 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Pharma Mar S.A..

Annual Capital Reinvestment Ratio for Pharma Mar S.A. (2012–2025)

Year-by-year Capital Reinvestment Ratio for Pharma Mar S.A. from 2012 to 2025. See PHM cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (EUR) Capital Expenditures YoY Change
2025 0.18x €53.13 Million €9.38 Million ▼ -93.1%
2024 2.57x €6.03 Million €15.51 Million ▲ +1014.1%
2022 0.23x €38.32 Million €8.85 Million ▼ -24.0%
2021 0.30x €25.68 Million €7.80 Million ▲ +2723.7%
2020 0.01x €278.94 Million €3.00 Million ▼ -98.7%
2015 0.83x €11.10 Million €9.22 Million ▲ +80.4%
2014 0.46x €22.11 Million €10.18 Million ▲ +259.2%
2013 0.13x €16.34 Million €2.10 Million ▼ -60.1%
2012 0.32x €6.32 Million €2.03 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow